Donate

Latest news & articles

Latest news
$3M invested for researchers working towards precision medicine for type 1 diabetes
News

$3M invested for researchers working towards precision medicine for type 1 diabetes

JDRF Australia and JDRF International have announced over $3m AUD in funding for researchers aiming to improve health outcomes for the type 1 diabetes (T1D) community by making precision medicine possible.   Precision medicine has delivered great benefits in other disease areas, such as cancer, and involves treatment that is tailored to a person’s genes, environment, […]
Our Volunteer of the Year winners 2024
News

Our Volunteer of the Year winners 2024

It’s National Volunteer Week and this year’s theme is ‘Something for Everyone’.   JDRF Australia was founded by volunteers in 1972, volunteers are at the core of all that we do, and we want to recognise and acknowledge all our volunteers who dedicate their time and effort to help us create a world without type […]
$6.5 million committed to JDRF Australia’s Type 1 Diabetes Clinical Research Network in Federal Budget
JDRF advocates

$6.5 million committed to JDRF Australia’s Type 1 Diabetes Clinical Research Network in Federal Budget

JDRF Australia is today welcoming $6.5 million in funding for the continuation of its Type 1 Diabetes Clinical Research Network (CRN), confirmed in the Albanese Government’s Federal Budget last night. The CRN is a critical vehicle for type 1 diabetes (T1D) research funding in Australia and has been accelerating T1D research advancements in Australia for […]
Exciting partnership: JDRF & SynxBody
News

Exciting partnership: JDRF & SynxBody

JDRF Australia has announced a new partnership with SynxBody Australia, an Australian footcare company, in a collaborative move towards enhancing awareness, education and support for Australians living with type 1 Diabetes (T1D).  SynxBody specialises in premium, affordable footcare products designed to effectively treat common ailments and enhance comfort for people from all walks of life. […]
Morning tea with Leader of the Opposition Hon Peter Dutton MP
JDRF advocates

Morning tea with Leader of the Opposition Hon Peter Dutton MP

JDRF’s advocacy program is all about helping decision makers understand what life with type 1 diabetes (T1D) is like and the difference their support could make.   Right now, there are advocates all over the country meeting with MPs to share their experiences living with T1D, and to tell them about the JDRF Type 1 Diabetes […]
Tips for young drivers with type 1 diabetes (and their parents)
Travel

Tips for young drivers with type 1 diabetes (and their parents)

Ready to get your driver licence – your Ls, Ps or full licence? It’s understandable that you can’t wait to hit the road (while your parents/carers may be a bit more nervous about it all!). As always, living with type 1 diabetes (T1D) shouldn’t stop you from living your best life – there are just […]
Australian researcher internationally recognised for achievements in type 1 diabetes screening
Research

Australian researcher internationally recognised for achievements in type 1 diabetes screening

We are proud to announce that Dr Kirstine Bell from the Charles Perkins Centre at The University of Sydney has been awarded the 2023 JDRF Dr Robert Goldstein Award for her notable contributions to type 1 diabetes (T1D) research. This is an internationally competitive award given to early career researchers who show great promise in […]
Funding to characterise a new target for type 1 diabetes prevention
Research

Funding to characterise a new target for type 1 diabetes prevention

JDRF is proud to announce new funding of $200,000 (USD) to Dr Irina Buckle from Mater Research and The University of Queensland, to undertake a project which aims to understand what may be driving type 1 diabetes.   Type 1 Diabetes (T1D) is a condition where certain types of immune cells, known as T cells, incorrectly […]
Sebastian’s Journey: Riding for awareness and change
Fundraising

Sebastian’s Journey: Riding for awareness and change

On Sunday 21 April 2024, a group of passionate cyclists are embarking on a wonderful fundraising initiative in memory of Sebastian Stafford, a cherished member of the type 1 diabetes (T1D) community.   Amateur cyclists from all areas of life will be taking on a 130km hard cycle from Bella Vista to the breathtaking Bowral to […]
New formulation of insulin may speed up its action for people with type 1 diabetes
Research

New formulation of insulin may speed up its action for people with type 1 diabetes

A research group from Norway has found that adding small amounts of glucagon to insulin speeds up its action. For people with type 1 diabetes (T1D) this would mean a faster acting insulin than what is on the market, and in turn, improved quality of life.    The need for fast insulin T1D is an autoimmune […]
Advocacy Spotlight: Meet Giselle
Advocacy

Advocacy Spotlight: Meet Giselle

Earlier this month, our advocates and the JDRF team were in Parliament House for the exciting research announcement regarding funding committed for five research projects in collaboration with the ENDIA study. In addition to this they were able to meet with key decision makers and discuss the reality of type 1 diabetes (T1D) along with the importance […]
New support for Australia’s best and brightest early career researchers
Research

New support for Australia’s best and brightest early career researchers

JDRF is delighted to announce that three Australian Early to Mid-Career Researchers (EMCRs) are being supported with over $2.2 million to continue their groundbreaking type 1 diabetes (T1D) research.   JDRF is committed to nurturing the growth and impact of leading independent researchers who are instrumental in translating scientific discoveries to clinical applications.  Dr Aveni Haynes […]
JDRF supports a medical corridor in the Middle East
Research

JDRF supports a medical corridor in the Middle East

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access to lifesaving supplies and medicines, like insulin, needed by all people living with T1D in the Middle East conflict zone. At all times, including times […]
$3 million invested to understand and prevent the development of T1D
Research

$3 million invested to understand and prevent the development of T1D

JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley) have committed $3 million for research projects aimed at understanding how type 1 diabetes (T1D) develops, with the ultimate goal of preventing it. This is in collaboration with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. ENDIA is the world’s first T1D observational […]
Advocacy Spotlight: Meet Joanne & Dougal
News

Advocacy Spotlight: Meet Joanne & Dougal

Dougal has been living with type 1 diabetes (T1D) since the age of 4, a journey that began when he complained of sore legs. Despite the absence of any family history of T1D, Joanne (Jo), a health professional and parent, quickly recognised the signs, drawing on her expertise and a colleague’s experience as a T1D […]
Community Spotlight: Meet Cara & Mya
News

Community Spotlight: Meet Cara & Mya

We recently sat down with an incredible mother, Cara, who has experienced the profound journey of caring for her young daughter Mya, with type 1 diabetes (T1D). Cara shares her diagnosis story, offers valuable insights into managing T1D day-to-day, and explains why she signed up for One Walk to fundraise for JDRF. Her hope for […]
Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated
Research

Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes (T1D), thanks to JDRF-funded Australian research that was published this week in the prestigious Nature journal. Why is this research important? During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in […]
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
Research

World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed

  A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, […]